This Article  • Full text  • PDF  • eTables  • JAMA Report Video  • Correction  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (4)  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in JAMA  Topic Collections  • Aging/ Geriatrics  • Neurology  • Alzheimer Disease  • Cognitive Disorders  • Dementias  • Complementary and Alternative Medicine  • Randomized Controlled Trial  • Prognosis/ Outcomes  • Drug Therapy  • Drug Therapy, Other  • Alert me on articles by topic  Social Bookmarking   What's this?

A Randomized Controlled Trial

Steven T. DeKosky, MD; Jeff D. Williamson, MD, MHS; Annette L. Fitzpatrick, PhD; Richard A. Kronmal, PhD; Diane G. Ives, MPH; Judith A. Saxton, MD; Oscar L. Lopez, MD; Gregory Burke, MD; Michelle C. Carlson, PhD; Linda P. Fried, MD, MPH; Lewis H. Kuller, MD, DrPH; John A. Robbins, MD, MHS; Russell P. Tracy, PhD; Nancy F. Woolard; Leslie Dunn, MPH; Beth E. Snitz, PhD; Richard L. Nahin, PhD, MPH; Curt D. Furberg, MD, PhD; for the Ginkgo Evaluation of Memory (GEM) Study Investigators

JAMA. 2008;300(19):2253-2262.

Context  Ginkgo biloba is widely used for its potential effects on memory and cognition. To date, adequately powered clinical trials testing the effect of G biloba on dementia incidence are lacking.

Objective  To determine effectiveness of G biloba vs placebo in reducing the incidence of all-cause dementia and Alzheimer disease (AD) in elderly individuals with normal cognition and those with mild cognitive impairment (MCI).

Design, Setting, and Participants  Randomized, double-blind, placebo-controlled clinical trial conducted in 5 academic medical centers in the United States between 2000 and 2008 with a median follow-up of 6.1 years. Three thousand sixty-nine community volunteers aged 75 years or older with normal cognition (n = 2587) or MCI (n = 482) at study entry were assessed every 6 months for incident dementia.

Intervention  Twice-daily dose of 120-mg extract of G biloba (n = 1545) or placebo (n = 1524).

Main Outcome Measures  Incident dementia and AD determined by expert panel consensus.

Results  Five hundred twenty-three individuals developed dementia (246 receiving placebo and 277 receiving G biloba) with 92% of the dementia cases classified as possible or probable AD, or AD with evidence of vascular disease of the brain. Rates of dropout and loss to follow-up were low (6.3%), and the adverse effect profiles were similar for both groups. The overall dementia rate was 3.3 per 100 person-years in participants assigned to G biloba and 2.9 per 100 person-years in the placebo group. The hazard ratio (HR) for G biloba compared with placebo for all-cause dementia was 1.12 (95% confidence interval [CI], 0.94-1.33; P = .21) and for AD, 1.16 (95% CI, 0.97-1.39; P = .11). G biloba also had no effect on the rate of progression to dementia in participants with MCI (HR, 1.13; 95% CI, 0.85-1.50; P = .39).

Conclusions  In this study, G biloba at 120 mg twice a day was not effective in reducing either the overall incidence rate of dementia or AD incidence in elderly individuals with normal cognition or those with MCI.

Trial Registration  clinicaltrials.gov Identifier: NCT00010803

Author Affiliations: University of Pittsburgh, Pittsburgh, Pennsylvania (Drs DeKosky, Saxton, Lopez, Kuller, and Snitz and Mss Ives and Dunn); Wake Forest University, Winston-Salem, North Carolina (Drs Williamson, Burke, and Furberg and Ms Woolard); University of Washington, Seattle (Drs Fitzpatrick and Kronmal); Johns Hopkins University, Baltimore, Maryland (Drs Carlson and Fried); University of California–Davis, Sacramento (Dr Robbins); University of Vermont, Burlington (Dr Tracy); National Center for Complementary and Alternative Medicine, Bethesda, Maryland (Dr Nahin); and University of Virginia, Charlottesville (Dr DeKosky).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?

RELATED ARTICLES

Ginkgo biloba Extract and Preventing Alzheimer Disease
Lon S. Schneider
JAMA. 2008;300(19):2306-2308.
EXTRACT | FULL TEXT  

Dementia
Janet M. Torpy, Cassio Lynm, and Richard M. Glass
JAMA. 2008;300(19):2330.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Functional and cognitive criteria produce different rates of mild cognitive impairment and conversion to dementia
Saxton et al.
J. Neurol. Neurosurg. Psychiatry 2009;80:737-743.
ABSTRACT | FULL TEXT  

How Much of CAM is Based on Research Evidence?
Ernst
Evid Based Complement Alternat Med 2009;0:nep044v1-nep044.
ABSTRACT | FULL TEXT  

Ginkgo biloba Prevention Trials: More Than an Ounce of Prevention Learned
Kaye
Arch Neurol 2009;66:652-654.
FULL TEXT  

Does Ginkgo biloba Prevent Dementia?
JWatch General 2008;2008:1-1.
FULL TEXT  

All you need to read in the other general journals
BMJ 2008;337:a2681-a2681.
FULL TEXT  

Ginkgo biloba Extract and Preventing Alzheimer Disease
Schneider
JAMA 2008;300:2306-2308.
FULL TEXT  

Ginkgo to Prevent Dementia? Forget About It.
JWatch Psychiatry 2008;2008:1-1.
FULL TEXT